Showing results (131-140 of 224) with videos related to
Sort By:
Pageof 23
Journal of Inflammation Research|June 30, 2026
Comparative Evaluation of Prolonged Dual Antiplatelet Therapy versus Conventional Regimens on Prognosis in Patients with High Residual Inflammatory Risk: Results from a Prospective Observational StudyZiyi Wang, Yanjun Song, Zhihao Zheng, et al.Diabetes & Metabolic Syndrome|March 22, 2024
Association of platelet-to-lymphocyte ratio levels with the risk of cardiac adverse events in people with type 2 diabetes undergoing percutaneous coronary intervention: A large-scale prospective cohort studyYanjun Song, Zhangyu Lin, Jining He, et al.Journal of Cellular Biochemistry|April 5, 2007
Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine heartsHaiyan Qian, Yuejin Yang, Ji Huang, et al.The American Journal of Medicine|June 8, 2025
Impact of Dual Antiplatelet Therapy Duration on Long-Term Outcomes Following Chronic Total Occlusion Percutaneous Coronary InterventionYao Jiang, Han Zhang, Chujie Zhang, et al.Journal of the American Heart Association|April 27, 2022
How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?Kongyong Cui, Dong Yin, Chenggang Zhu, et al.Diabetes/Metabolism Research and Reviews|March 10, 2026
Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro-Metabolic Axis in Type 2 DiabetesYanjun Song, Xinyue Chen, Zhen'ge Chang, et al.Angiology|January 7, 2017
Comparison of Transradial and Transfemoral Approaches in Women Undergoing Percutaneous Coronary Intervention in China: A Retrospective Observational StudyChen Jin, Yi Xu, Shubin Qiao, et al.Age and Ageing|November 11, 2025
Residual atherosclerotic risk in older patients with atherosclerotic cardiovascular disease: where inflammation meets lipoprotein(a)Xiaohui Bian, Hao-Yu Wang, Yuanlin Guo, et al.American Journal of Preventive Cardiology|April 11, 2025
Optimizing Long-term Cardiovascular Risk Stratification: Integrating Biomarkers into the Very High-Risk ASCVD Definition in Asian PatientsJiaxi Cheng, Hao-Yu Wang, Chenxi Song, et al.Frontiers in Cardiovascular Medicine|January 6, 2022
Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) ConcentrationsKongyong Cui, Hao-Yu Wang, Dong Yin, et al.Pageof 23